5:17 PM ET
8-K
Executive Compensation
Lunai Bioworks Executive Compensation
Lunai Bioworks entered into an amended employment agreement with CEO David Weinstein, reducing his annual base salary from $400,000 to $275,000. Weinstein waived his rights to severance and accelerated vesting, and his employment term was set to end on December 28, 2026. The agreement also terminates his non-competition and non-solicitation covenants while deferring his October 2026 salary payment.
- Counterparty
- David Weinstein
- Term
- through Dec 2026